05/11/2025
London, United Kingdom – 05.11.2025 — CleverSkin Technologies Limited proudly announces its participation in MEDICA 2025, the world’s leading medical trade fair, taking place in Düsseldorf, Germany. The company will present its innovative wound care solution – CleverSkin, an advanced polyurethane-based wound dressing with nanocrystalline additives, designed to accelerate healing and reduce infection risks.
CleverSkin represents a new generation of medical dressings, combining cutting-edge materials science with clinical practicality. The product has been engineered to provide superior moisture balance, breathability, and antibacterial protection — setting a new benchmark in wound management and post-operative care.
At MEDICA 2025, CleverSkin Technologies will welcome angel investors, venture capital funds, Series A investors, entrepreneurs, as well as NHS-approved distributors, hospitals, and clinics to explore cooperation opportunities. The company aims to expand its global network of strategic partners for manufacturing, licensing, and distribution in the UK, EU, ASEAN, and other key regions.
“Our mission is to make advanced wound care accessible worldwide,” said CEO and Founder of CleverSkin Technologies, Mr Vadzim Tsitou. “MEDICA provides the ideal platform to connect with partners who share our vision of improving patient recovery through innovation.”
CleverSkin Technologies Limited invites all interested parties to schedule a meeting during the exhibition to discuss investment, distribution, and partnership opportunities.
Event: MEDICA 2025
Location: Messe Düsseldorf, Germany
Dates: 17–20 November 2025
Booth: Hall5/D32
Website: https://cleverskintechnologies.co.uk
Email for appointments: https://cleverskintechnologies.co.uk/#contact
CleverSkin Technologies Limited is a London-based medical innovation company developing next-generation wound care and skin protection products. Its flagship product, CleverSkin, integrates nanotechnology and advanced polyurethane materials to deliver superior healing performance and patient comfort.